Chugai Pharmaceutical Co., Ltd. CHGCF
OTC PK
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Net Income | -- | 1.55B | 1.32B | 1.30B | |
| Total Depreciation and Amortization | -- | 203.24M | 199.03M | 199.69M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -1.76B | -1.63B | -1.69B | |
| Change in Net Operating Assets | -- | 2.59B | 2.86B | 3.28B | |
| Cash from Operations | -- | 2.58B | 2.75B | 3.10B | |
| Capital Expenditure | -- | -511.11M | -397.13M | -447.37M | |
| Sale of Property, Plant, and Equipment | -- | 51.90M | 47.11M | 47.59M | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -845.96M | -16.61M | -856.50M | |
| Cash from Investing | -- | -1.31B | -366.63M | -1.26B | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | 3.96B | 4.11B | 4.01B | |
| Issuance of Common Stock | -- | 142.00M | 146.00M | 200.00M | |
| Repurchase of Common Stock | -- | -6.00M | -4.00M | -7.00M | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -2.01B | -2.01B | -1.07B | |
| Other Financing Activities | -- | -12.56B | -12.09B | -11.99B | |
| Cash from Financing | -- | -2.07B | -2.07B | -1.12B | |
| Foreign Exchange rate Adjustments | -- | 62.18M | 47.73M | -9.53M | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -6.60K | 6.90K | |
| Net Change in Cash | -- | -725.49M | 361.45M | 705.74M | |